BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 27489275)

  • 1. Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
    Manivannan S; Baxter VK; Schultz KL; Slusher BS; Griffin DE
    J Virol; 2016 Oct; 90(20):9251-62. PubMed ID: 27489275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.
    Baxter VK; Glowinski R; Braxton AM; Potter MC; Slusher BS; Griffin DE
    Virology; 2017 Aug; 508():134-149. PubMed ID: 28531865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.
    Potter MC; Baxter VK; Mathey RW; Alt J; Rojas C; Griffin DE; Slusher BS
    J Neurovirol; 2015 Apr; 21(2):159-73. PubMed ID: 25645378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage.
    Griffin DE
    Neurotherapeutics; 2016 Jul; 13(3):455-60. PubMed ID: 27114366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection.
    Greene IP; Lee EY; Prow N; Ngwang B; Griffin DE
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3575-80. PubMed ID: 18296635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis.
    Kulcsar KA; Baxter VK; Abraham R; Nelson A; Griffin DE
    J Virol; 2015 Aug; 89(16):8280-91. PubMed ID: 26041298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate receptor antagonists protect from virus-induced neural degeneration.
    Nargi-Aizenman JL; Havert MB; Zhang M; Irani DN; Rothstein JD; Griffin DE
    Ann Neurol; 2004 Apr; 55(4):541-9. PubMed ID: 15048893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 Modulation of Virus Clearance and Disease in Mice with Alphaviral Encephalomyelitis.
    Martin NM; Griffin DE
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis.
    Prow NA; Irani DN
    Exp Neurol; 2007 Jun; 205(2):461-70. PubMed ID: 17459376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB Activation Promotes Alphavirus Replication in Mature Neurons.
    Yeh JX; Park E; Schultz KLW; Griffin DE
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis.
    Irani DN; Prow NA
    J Neuropathol Exp Neurol; 2007 Jun; 66(6):533-44. PubMed ID: 17549013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ Line IgM Is Sufficient, but Not Required, for Antibody-Mediated Alphavirus Clearance from the Central Nervous System.
    Nilaratanakul V; Chen J; Tran O; Baxter VK; Troisi EM; Yeh JX; Griffin DE
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antibody in recovery from alphavirus encephalitis.
    Griffin D; Levine B; Tyor W; Ubol S; Desprès P
    Immunol Rev; 1997 Oct; 159():155-61. PubMed ID: 9416509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.
    Baxter VK; Griffin DE
    J Gen Virol; 2016 Nov; 97(11):2908-2925. PubMed ID: 27667782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.
    Metcalf TU; Baxter VK; Nilaratanakul V; Griffin DE
    J Virol; 2013 Mar; 87(5):2420-9. PubMed ID: 23255791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus.
    Thach DC; Kimura T; Griffin DE
    J Virol; 2000 Jul; 74(13):6156-61. PubMed ID: 10846099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons.
    Binder GK; Griffin DE
    Science; 2001 Jul; 293(5528):303-6. PubMed ID: 11452126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal cell death in alphavirus encephalomyelitis.
    Griffin DE
    Curr Top Microbiol Immunol; 2005; 289():57-77. PubMed ID: 15791951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus.
    Kimura T; Griffin DE
    Virology; 2003 Jun; 311(1):28-39. PubMed ID: 12832200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3 Macrodomain Affect Neurovirulence in Mice.
    Abraham R; McPherson RL; Dasovich M; Badiee M; Leung AKL; Griffin DE
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.